CoChat
Sign Up
Cited by 289Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsCerebral Venous Sinus Thrombosis

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.

McRae, Simon, Tran, Huyen, Schulman, Sam, Ginsberg, Jeff, Kearon, Clive·2006·The Lancet
DOI 10.1016/s0140-6736(06)69110-1
Open this paper in CoChat — free account

Abstract

Background Individual risk of recurrent venous thromboembolism affects patient management and might differ between men and women. We did a meta-analysis to assess from available evidence whether men and women have the same risk of recurrent venous thromboembolism after stopping anticoagulant treatment.Methods Eligible articles were identified by searches of MEDLINE (source PubMed, 1966 to February 2005), EMBase (1980 to February 2005), and the Cochrane database 2005, issue 1. Prospective cohort studies and randomised trials were eligible if they included patients with objectively diagnosed venous thromboembolism treated for a minimum of 1 month and followed up for recurrence after anticoagulant treatment was stopped. Data were extracted for study design, study quality, and the number, sex, and age of enrolled patients, risk factors for venous thromboembolism, treatment given, duration of follow-up, and the number of episodes of recurrent venous thrombosis.Findings 15 studies (nine randomised controlled trials and six prospective observational studies) enrolling a total of 5416 individuals (2729 men), of whom 816 (523 men) had recurrent venous thromboembolism after stopping treatment, were eligible for inclusion. The pooled estimate of the relative risk (RR) of recurrent venous thromboembolism for men compared with for women was 1.6 (95% CI 1.2-2.0). Significant heterogeneity was shown among individual study findings; however, the higher risk of recurrent venous thromboembolism in men than in women was consistent across predefined subgroups. The relative risk for recurrence in men from randomised trials (RR 1.3; 95% CI 1.0-1.8) was lower than that from observational studies (2.1; 1.5-2.9). The lower risk of recurrent venous thromboembolism in women did not seem to be accounted for by a reduced rate of recurrence after venous thromboembolism associated with oestrogen treatment or pregnancy.Interpretation Men seem to have a 50% higher risk than women of recurrent venous thromboembolism after stopping anticoagulant treatment. If confirmed by further prospective studies, this difference in risk of recurrence should be considered when duration of anticoagulant treatment is determined in individual patients.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(06)69110-1

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Cited by

Sorted by citations

Items 101–200 of 288

Related

See all

Metadata

Authors
McRae, S., Tran, H., Schulman, S., Ginsberg, J., & Kearon, C.
Affiliations
  • McMaster University Medical Centre (CA)
  • Hamilton General Hospital (CA)
  • McMaster University (CA)
Corresponding author
McRae, Simon
ORCID
Venue
The Lancet
Publisher
Elsevier BV
Published
2006-07
Volume
368
Issue
9533
Pages
371-378
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(06)69110-1
OpenAlex
W2129839379
Cited by
289
References
37
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 13 · 2021: 8 · 2020: 13 · 2019: 12 · 2018: 11 · 2017: 8 · 2016: 23 · 2015: 22 · 2014: 18 · 2013: 21 · 2012: 21
FWCI
4.39
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
Keywords
sex differences, anticoagulation, anticoagulation discontinuation, men versus women, anticoagulation duration, estrogen therapy, pregnancy, venous thromboembolism risk
MeSH terms
Aged, Anticoagulants, Female, Humans, Hypertension, Pulmonary, Male, Middle Aged, Recurrence, Risk Factors, Randomized Controlled Trials as Topic, Sex Distribution, Venous Thrombosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review